These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 32329374)
1. Gefitinib loaded nanostructured lipid carriers: characterization, evaluation and anti-human colon cancer activity Makeen HA; Mohan S; Al-Kasim MA; Attafi IM; Ahmed RA; Syed NK; Sultan MH; Al-Bratty M; Alhazmi HA; Safhi MM; Ali R; Intakhab Alam M Drug Deliv; 2020 Dec; 27(1):622-631. PubMed ID: 32329374 [TBL] [Abstract][Full Text] [Related]
2. Development and optimization of sulforaphane-loaded nanostructured lipid carriers by the Box-Behnken design for improved oral efficacy against cancer: in vitro, ex vivo and in vivo assessments. Soni K; Rizwanullah M; Kohli K Artif Cells Nanomed Biotechnol; 2018; 46(sup1):15-31. PubMed ID: 29183147 [TBL] [Abstract][Full Text] [Related]
3. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy. Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015 [TBL] [Abstract][Full Text] [Related]
4. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s). Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192 [TBL] [Abstract][Full Text] [Related]
5. Orcinol Glucoside Loaded Polymer - Lipid Hybrid Nanostructured Lipid Carriers: Potential Cytotoxic Agents against Gastric, Colon and Hepatoma Carcinoma Cell Lines. Nahak P; Gajbhiye RL; Karmakar G; Guha P; Roy B; Besra SE; Bikov AG; Akentiev AV; Noskov BA; Nag K; Jaisankar P; Panda AK Pharm Res; 2018 Aug; 35(10):198. PubMed ID: 30151753 [TBL] [Abstract][Full Text] [Related]
6. Preparation, Characterization, and Anti-Cancer Activity of Nanostructured Lipid Carriers Containing Imatinib. Makeen HA; Mohan S; Al-Kasim MA; Sultan MH; Albarraq AA; Ahmed RA; Alhazmi HA; Alam MI Pharmaceutics; 2021 Jul; 13(7):. PubMed ID: 34371776 [TBL] [Abstract][Full Text] [Related]
7. Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery. Noor NM; Sheikh K; Somavarapu S; Taylor KMG Eur J Pharm Biopharm; 2017 Aug; 117():372-384. PubMed ID: 28412472 [TBL] [Abstract][Full Text] [Related]
8. Optimization of Gefitinib-Loaded Nanostructured Lipid Carrier as a Biomedical Tool in the Treatment of Metastatic Lung Cancer. Sherif AY; Harisa GI; Shahba AA; Alanazi FK; Qamar W Molecules; 2023 Jan; 28(1):. PubMed ID: 36615641 [TBL] [Abstract][Full Text] [Related]
9. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers. Wang W; Chen L; Huang X; Shao A AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090 [TBL] [Abstract][Full Text] [Related]
11. Systematic implementation of quality-by-design (QbD) to develop NSAID-loaded nanostructured lipid carriers for ocular application: preformulation screening studies and statistical hybrid-design for optimization of variables. Rathod VR; Shah DA; Dave RH Drug Dev Ind Pharm; 2020 Mar; 46(3):443-455. PubMed ID: 32037896 [TBL] [Abstract][Full Text] [Related]
12. Preparation and characterization of nanostructured lipid carriers as drug delivery system: Influence of liquid lipid types on loading and cytotoxicity. Saedi A; Rostamizadeh K; Parsa M; Dalali N; Ahmadi N Chem Phys Lipids; 2018 Nov; 216():65-72. PubMed ID: 30219661 [TBL] [Abstract][Full Text] [Related]
13. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization. Nagaich U; Gulati N Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979 [TBL] [Abstract][Full Text] [Related]
14. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation. Khan S; Baboota S; Ali J; Narang RS; Narang JK Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780 [TBL] [Abstract][Full Text] [Related]
15. In vivo Antiplasmodial Activity of Curcumin-Loaded Nanostructured Lipid Carriers. Rashidzadeh H; Salimi M; Sadighian S; Rostamizadeh K; Ramazani A Curr Drug Deliv; 2019; 16(10):923-930. PubMed ID: 31663477 [TBL] [Abstract][Full Text] [Related]
16. Targeted Nanostructured Lipid Carrier for Brain Delivery of Artemisinin: Design, Preparation, Characterization, Optimization and Cell Toxicity. Emami J; Yousefian H; Sadeghi H J Pharm Pharm Sci; 2018; 21(1s):225s-241s. PubMed ID: 30266137 [TBL] [Abstract][Full Text] [Related]
17. Targeted Nanostructured Lipid Carriers for Delivery of Paclitaxel to Cancer Cells: Preparation, Characterization, and Cell Toxicity. Rezazadeh M; Emami J; Hassanzadeh F; Sadeghi H; Rostami M; Mohammadkhani H Curr Drug Deliv; 2017; 14(8):1189-1200. PubMed ID: 28472908 [TBL] [Abstract][Full Text] [Related]
18. Modulation of Pharmacokinetic and Cytotoxicity Profile of Imatinib Base by Employing Optimized Nanostructured Lipid Carriers. Gupta B; Poudel BK; Tran TH; Pradhan R; Cho HJ; Jeong JH; Shin BS; Choi HG; Yong CS; Kim JO Pharm Res; 2015 Sep; 32(9):2912-27. PubMed ID: 25939551 [TBL] [Abstract][Full Text] [Related]